271 related articles for article (PubMed ID: 22533409)
21. The effect of passively acquired antibodies on Lawsonia intracellularis infection and immunity in the horse.
Page AE; Stills HF; Horohov DW
Equine Vet J; 2015 Nov; 47(6):655-61. PubMed ID: 25138347
[TBL] [Abstract][Full Text] [Related]
22. Re-challenge of pigs following recovery from proliferative enteropathy.
Collins AM; Love RJ
Vet Microbiol; 2007 Mar; 120(3-4):381-6. PubMed ID: 17188822
[TBL] [Abstract][Full Text] [Related]
23. Species-specificity of equine and porcine Lawsonia intracellularis isolates in laboratory animals.
Sampieri F; Vannucci FA; Allen AL; Pusterla N; Antonopoulos AJ; Ball KR; Thompson J; Dowling PM; Hamilton DL; Gebhart CJ
Can J Vet Res; 2013 Oct; 77(4):261-72. PubMed ID: 24124268
[TBL] [Abstract][Full Text] [Related]
24. Lawsonia intracellularis proliferative enteropathy in a foal.
Feary DJ; Gebhart CJ; Pusterla N
Schweiz Arch Tierheilkd; 2007 Mar; 149(3):129-33. PubMed ID: 17410971
[TBL] [Abstract][Full Text] [Related]
25. Lawsonia intracellularis and equine proliferative enteropathy.
Page AE; Slovis NM; Horohov DW
Vet Clin North Am Equine Pract; 2014 Dec; 30(3):641-58. PubMed ID: 25300636
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in understanding the pathogenesis of Lawsonia intracellularis infections.
Vannucci FA; Gebhart CJ
Vet Pathol; 2014 Mar; 51(2):465-77. PubMed ID: 24476941
[TBL] [Abstract][Full Text] [Related]
27. Detection of Lawsonia intracellularis by real-time PCR in the feces of free-living animals from equine farms with documented occurrence of equine proliferative enteropathy.
Pusterla N; Mapes S; Rejmanek D; Gebhart C
J Wildl Dis; 2008 Oct; 44(4):992-8. PubMed ID: 18957657
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions.
Jacobs AAC; Harks F; Hazenberg L; Hoeijmakers MJH; Nell T; Pel S; Segers RPAM
Vaccine; 2019 Apr; 37(15):2149-2157. PubMed ID: 30867100
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of virulence of Lawsonia intracellularis after in vitro passages and its effects on the experimental reproduction of porcine proliferative enteropathy.
Vannucci FA; Beckler D; Pusterla N; Mapes SM; Gebhart CJ
Vet Microbiol; 2013 Feb; 162(1):265-9. PubMed ID: 22939985
[TBL] [Abstract][Full Text] [Related]
30. Lawsonia intracellularis associated equine proliferative enteropathy in Danish weanling foals.
Bohlin AM; Olsen SN; Laursen SH; Öhman A; van Galen G
Acta Vet Scand; 2019 Mar; 61(1):12. PubMed ID: 30850006
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and epidemiological features of Lawsonia intracellularis enteropathy in 2 foals.
Dauvillier J; Picandet V; Harel J; Gottschalk M; Desrosiers R; Jean D; Lavoie JP
Can Vet J; 2006 Jul; 47(7):689-91. PubMed ID: 16898113
[TBL] [Abstract][Full Text] [Related]
32. Effects of oral vaccination against Lawsonia intracellularis on growing-finishing pig's performance in a pig production unit with endemic porcine proliferative enteropathy (PPE).
Almond PK; Bilkei G
Dtsch Tierarztl Wochenschr; 2006 Jun; 113(6):232-5. PubMed ID: 16856610
[TBL] [Abstract][Full Text] [Related]
33. Comparison of feces versus rectal swabs for the molecular detection of Lawsonia intracellularis in foals with equine proliferative enteropathy.
Pusterla N; Mapes S; Johnson C; Slovis N; Page A; Gebhart C
J Vet Diagn Invest; 2010 Sep; 22(5):741-4. PubMed ID: 20807932
[TBL] [Abstract][Full Text] [Related]
34. Equine Proliferative Enteropathy in Weanling Foals on A German Breeding Farm: Clinical Course, Treatment and Long-Term Outcome.
Dohrmann J; Hildebrand F; Straub J; Wadephul R; Pusterla N; Freise F; Venner M
J Equine Vet Sci; 2022 Apr; 111():103873. PubMed ID: 35074397
[TBL] [Abstract][Full Text] [Related]
35. A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function.
Roerink F; Morgan CL; Knetter SM; Passat MH; Archibald AL; Ait-Ali T; Strait EL
Vaccine; 2018 Mar; 36(11):1500-1508. PubMed ID: 29336925
[TBL] [Abstract][Full Text] [Related]
36. Immunological responses to vaccination following experimental Lawsonia intracellularis virulent challenge in pigs.
Nogueira MG; Collins AM; Donahoo M; Emery D
Vet Microbiol; 2013 May; 164(1-2):131-8. PubMed ID: 23478250
[TBL] [Abstract][Full Text] [Related]
37. Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy.
Montesino R; Gutiérrez N; Camacho F; Farnós O; Andrades S; González A; Acosta J; Cortez-San Martín M; Sánchez O; Ruiz A; Toledo JR
Vaccine; 2019 Feb; 37(10):1340-1349. PubMed ID: 30711318
[TBL] [Abstract][Full Text] [Related]
38. Experimental reproduction of proliferative enteropathy and the role of IFN-gamma in protective immunity against Lawsonia intracellularis in mice.
Go YY; Lee JK; Ye JY; Lee JB; Park SY; Song CS; Kim SK; Choi IS
J Vet Sci; 2005 Dec; 6(4):357-9. PubMed ID: 16294002
[TBL] [Abstract][Full Text] [Related]
39. The influence of diet on Lawsonia intracellularis colonization in pigs upon experimental challenge.
Boesen HT; Jensen TK; Schmidt AS; Jensen BB; Jensen SM; Møller K
Vet Microbiol; 2004 Oct; 103(1-2):35-45. PubMed ID: 15381264
[TBL] [Abstract][Full Text] [Related]
40. Lawsonia intracellularis proliferative enteropathy in a weanling foal in Australia.
McClintock SA; Collins AM
Aust Vet J; 2004 Dec; 82(12):750-2. PubMed ID: 15648934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
